Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent

Osteoporosis International

Volumn 22, Issue 3, 2011, Pages 781-787

  Kim, S H ^a   Choi, H S ^b   Rhee, Y ^c   Kim, K J ^c   Lim, S K ^c,d  

^a Catholic Kwandong University   (South Korea)

^b Dongguk University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Alendronate; Bone density; Osteoporosis; Raloxifene; Vertebral fracture

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; RALOXIFENE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE RADIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KOREA; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VERTEBRA FRACTURE;

AGE FACTORS; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PREVALENCE; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL FRACTURES;

EID: 79951676160     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1298-y     Document Type: Article

References (24)

1. PD Ross 1997 Clinical consequences of vertebral fractures Am J Med 103 suppl 30S 43S 1:STN:280:DyaK2svkvVGluw%3D%3D 10.1016/S0002-9343(97)90025-5 9302895 (Pubitemid 27386440)
2. DM Kado WS Browner L Palermo MC Nevitt HK Genant SR Cummings 1999 Vertebral fractures and mortality in older women: a prospective study. Study of osteoporotic fractures research group Arch Intern Med 159 1215 1220 1:STN:280:DyaK1M3pslKguw%3D%3D 10.1001/archinte.159.11.1215 10371229 (Pubitemid 29269861)
3. SR Cummings LJ Melton 2002 Epidemiology and outcomes of osteoporotic fractures Lancet 359 1761 1767 10.1016/S0140-6736(02)08657-9 12049882 (Pubitemid 34614532)
4. R Linsay SL Silverman C Cooper DA Hanley I Barton SB Broy A Licata L Benhamou P Geusens K Flowers H Stracke E Seeman 2001 Risk of new vertebral fracture in the year following a fracture JAMA 285 320 323 10.1001/jama.285.3. 320 (Pubitemid 32095035)
5. O Johnell A Oden F Caulin JA Kanis 2001 Acute and long-term increase in fracture risk after hospitalization for vertebral fracture Osteoporosis Int 12 207 214 1:STN:280:DC%2BD3M3oslKrsA%3D%3D 10.1007/s001980170131 (Pubitemid 32288937)
6. PD Ross JW Davis RS Epstein RD Wasnich 1991 Pre-existing fractures and bone mass predict vertebral fracture incidence in women Ann Intern Med 114 919 923 1:STN:280:DyaK3M3itFCisQ%3D%3D 2024857
7. JA Kanis O Johnell C De Laet H Johansson A Oden P Delmas J Eisman S Fujiwara P Garnero H Kroger EV McCloskey D Mellstrom LJ Melton H Pols J Reeve A Silman A Tenenhouse 2004 A meta-analysis of previous fracture and subsequent fracture risk Bone 35 375 382 1:STN:280:DC%2BD2czmsVCntg%3D%3D 10.1016/j.bone.2004.03.024 15268886 (Pubitemid 38953182)
8. DM Black NK Arden L Palermo J Pearson SR Cummings 1999 Prevalent vertebral deformities predict hip fractures and new vertebral fractures but not wrist fractures. Study of osteoporotic fracture research group J Bone Miner Res 14 821 828 1:STN:280:DyaK1M3lsFyjtw%3D%3D 10.1359/jbmr.1999.14.5.821 10320531 (Pubitemid 29210609)
9. M Lunt TW O'Neill D Felsenberg J Reeve JA Kanis C Cooper AJ Silman 2003 Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS) Bone 33 505 513 10.1016/S8756-3282(03)00248-5 14555253 (Pubitemid 37222376)
10. ES Siris HK Genant AJ Laster P Chen DA Misurski JH Krege 2007 Enhanced prediction of fracture risk combining vertebral fracture status and BMD Osteoporos Int 18 761 770 1:STN:280:DC%2BD2s3mt1Sluw%3D%3D 10.1007/s00198-006- 0306-8 17245546 (Pubitemid 46684783)
11. MA Katowics LJ Melton III C Copper EJ Atkinson WM O'fallon BL Riggs 1994 Risk of hip fracture in women with vertebral fracture J Bone Miner Res 9 599 605 10.1002/jbmr.5650090503 (Pubitemid 24130459)
12. National Osteoporosis Foundation (2005) Physician guide to prevention and treatment of osteoporosis. Available at http://www.nof.org/physguide/index.htm. Accessed January 15, 2005
13. PD Delmas R Rizzoli C Cooper JY Reginster 2005 Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation Osteoporos Int 16 1 5 10.1007/s00198-004-1813-0 15565349 (Pubitemid 40193213)
14. E Barrett-Connor ES Siris LE Wehren PD Miller TA Abbott ML Berger AC Santora LM Sherwood 2005 Osteoporosis and fracture risk in women of different ethnic groups J Bone Miner Res 20 185 194 10.1359/JBMR.041007 15647811
15. HK Genant CY Wu C Van Kuijk M Nevitt 1993 Vertebral fracture assessment using a SQ technique J Bone Miner Res 8 1137 1148 1:STN:280: DyaK2c%2FlsFyhuw%3D%3D 10.1002/jbmr.5650080915 8237484 (Pubitemid 23261108)
16. CM Klotzbuecher PD Ross PB Landsman TA Abbott III M Berger 2000 Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis J Bone Miner Res 15 721 739 1:STN:280:DC%2BD3c3ktFOktA%3D%3D 10.1359/jbmr.2000.15.4.721 10780864 (Pubitemid 30174026)
17. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud 1996 Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535 1541 1:CAS:528:DyaK2sXisFCktQ%3D%3D 10.1016/S0140-6736(96)07088-2 8950879 (Pubitemid 26411651)
18. ST Harris NB Watts HK Genant CD McKeever T Hangartner M Keller CH Chesnut 3rd BJ Eriksen HMS EF DW Axelrod PD Miller 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial JAMA 282 1344 1352 1:CAS:528:DyaK1MXmvFansr0%3D 10.1001/jama.282.14.1344 10527181 (Pubitemid 29483192)
19. CH Chesnut III A Skag C Christiansen R Recker JA Stakkestad A Hoiseth D Felsenberg H Huss J Gilbride RC Schimmer PD Delmas 2004 Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis J Bone Miner Res 19 1241 1249 1:CAS:528: DC%2BD2cXntFGqurw%3D 10.1359/JBMR.040325 (Pubitemid 41094364)
20. SR Cummings DM Black DE Thompson WB Applegate E Barrett-Connor TA Musliner L Palermo R Prineas SM Rubin JC Scott T Vogt R Wallace AJ Yates AZ Lacroix 1998 Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial JAMA 280 2077 2082 1:CAS:528:DyaK1MXjsVWruw%3D%3D 10.1001/jama.280.24.2077 9875874 (Pubitemid 29014065)
21. B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Glüer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282 637 645 1:CAS:528:DyaK1MXlvVKqurg%3D 10.1001/jama.282.7.637 10517716 (Pubitemid 29384151)
22. Lee SH, Khang YH, Lim KH, Kim BJ, Koh JM, Kim GS, Kim H, Cho NH (2010) Clinical risk factors for osteoporotic fracture: a population-base prospective cohort study in Korea. J Bone Miner Res 25:369-378
23. DA Grimes KF Schulz 2009 Bias and causal associations in observational research Lancet 359 248 252 10.1016/S0140-6736(02)07451-2
24. PD Delmas HK Genant GG Crans JL Stock M Wong E Siris JD Adachi 2003 Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial Bone 33 522 532 1:STN:280:DC%2BD3svnslSgsw%3D%3D 10.1016/S8756-3282(03)00241-2 14555255 (Pubitemid 37222378)